Legal Opinion
Amos ex rel. Estate of Amos v. Biogen Idec Inc.
District Court, W.D. New York
Decided June 25, 2014No. 13-CV-6375TPublishedCited by 19 opinions
1Opinion of the Court
DECISION and ORDER
MICHAEL A. TELESCA, District Judge.
INTRODUCTION
Plaintiff Gregory A. Amos, the widower of Andrea R. Amos (“Amos”) and administrator of her estate, brings this wrongful death action against defendants Biogen Idee Inc., (“Biogen”) and Elan Pharmaceuticals, Inc. (“Elan”) claiming that Andrea Amos died as the direct result of taking the prescription drug Tysabri, which was developed, marketed, and sold by the defendants. Specifically, plaintiff claims that Amos’s use of the drug Tysabri caused her to develop a fatal infection in her brain.
Plaintiffs Complaint alleges nine…
2Cases cited23 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Conley v. GibsonSupreme Court of the United States · 1957
- Ruotolo v. City of New YorkCourt of Appeals for the Second Circuit · 2008
- Hayden v. PatersonCourt of Appeals for the Second Circuit · 2010
- Oswego Laborers' Local 214 Pension Fund v. Marine Midland Bank, N. A.New York Court of Appeals · 1995
18 more not listed; retrieve them via the Exa API.
3Cited by19 opinions
- Greene v. Gerber Products Co.District Court, E.D. New York · 2017
- Yates v. Ortho-McNeil-Janssen Pharmaceuticals, Inc.Court of Appeals for the Sixth Circuit · 2015
- Schwartzco Enterprises LLC v. TMH Management, LLCDistrict Court, E.D. New York · 2014
- Silvercreek Management, Inc. v. Citigroup, Inc.District Court, S.D. New York · 2017
- Trisvan v. HeymanDistrict Court, E.D. New York · 2018
14 more not listed; retrieve them via the Exa API.